These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 8093351)
1. High level expression of the homeobox gene HB24 in a human T-cell line confers the ability to form tumors in nude mice. Deguchi Y; Kehrl JH Cancer Res; 1993 Jan; 53(2):373-7. PubMed ID: 8093351 [TBL] [Abstract][Full Text] [Related]
2. NK cell-mediated anti-tumor immune response to human prostate cancer cell, PC-3: immunogene therapy using a highly secretable form of interleukin-15 gene transfer. Suzuki K; Nakazato H; Matsui H; Hasumi M; Shibata Y; Ito K; Fukabori Y; Kurokawa K; Yamanaka H J Leukoc Biol; 2001 Apr; 69(4):531-7. PubMed ID: 11310838 [TBL] [Abstract][Full Text] [Related]
3. Phorbol ester-mediated inhibition of growth and regulation of proto-oncogene expression in the human T cell leukemia line JURKAT. Makover D; Cuddy M; Yum S; Bradley K; Alpers J; Sukhatme V; Reed JC Oncogene; 1991 Mar; 6(3):455-60. PubMed ID: 2011401 [TBL] [Abstract][Full Text] [Related]
4. Interleukin 3 enhances development of tumor-reactive cytotoxic cells by a CD4-dependent mechanism. Pulaski BA; McAdam AJ; Hutter EK; Biggar S; Lord EM; Frelinger JG Cancer Res; 1993 May; 53(9):2112-7. PubMed ID: 8097675 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2. Nagashima S; Reichert TE; Kashii Y; Suminami Y; Chikamatsu K; Whiteside TL Cancer Gene Ther; 1997; 4(6):366-76. PubMed ID: 9408607 [TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity. Hwang KS; Cho WK; Yoo J; Seong YR; Kim BK; Kim S; Im DS Cancer Gene Ther; 2004 Jun; 11(6):397-407. PubMed ID: 15044962 [TBL] [Abstract][Full Text] [Related]
7. Stable expression of HB24, a diverged human homeobox gene, in T lymphocytes induces genes involved in T cell activation and growth. Deguchi Y; Thevenin C; Kehrl JH J Biol Chem; 1992 Apr; 267(12):8222-9. PubMed ID: 1349016 [TBL] [Abstract][Full Text] [Related]
8. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice. Zhang F; Lee J; Lu S; Pettaway CA; Dong Z Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637 [TBL] [Abstract][Full Text] [Related]
9. Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor. Pötgens AJ; van Altena MC; Lubsen NH; Ruiter DJ; de Waal RM Am J Pathol; 1996 Apr; 148(4):1203-17. PubMed ID: 8644861 [TBL] [Abstract][Full Text] [Related]
10. High expression of two diverged homeobox genes, HB24 and HB9, in acute leukemias: molecular markers of hematopoietic cell immaturity. Deguchi Y; Yamanaka Y; Theodossiou C; Najfeld V; Kehrl JH Leukemia; 1993 Mar; 7(3):446-51. PubMed ID: 7680402 [TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer. Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460 [TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human IL-2 cDNA: induction of CD8(+) T-cell immunity and NK activity. Slos P; De Meyer M; Leroy P; Rousseau C; Acres B Cancer Gene Ther; 2001 May; 8(5):321-32. PubMed ID: 11477452 [TBL] [Abstract][Full Text] [Related]
13. Successful immunogene therapy using colon cancer cells (colon 26) transfected with plasmid vector containing mature interleukin-18 cDNA and the Igkappa leader sequence. Yoshimura K; Hazama S; Iizuka N; Yoshino S; Yamamoto K; Muraguchi M; Ohmoto Y; Noma T; Oka M Cancer Gene Ther; 2001 Jan; 8(1):9-16. PubMed ID: 11219497 [TBL] [Abstract][Full Text] [Related]
14. Natural killer cell-dependent suppression of systemic spread of human lung adenocarcinoma cells by monocyte chemoattractant protein-1 gene transfection in severe combined immunodeficient mice. Nokihara H; Yanagawa H; Nishioka Y; Yano S; Mukaida N; Matsushima K; Sone S Cancer Res; 2000 Dec; 60(24):7002-7. PubMed ID: 11156403 [TBL] [Abstract][Full Text] [Related]
15. Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells. Ferrantini M; Proietti E; Santodonato L; Gabriele L; Peretti M; Plavec I; Meyer F; Kaido T; Gresser I; Belardelli F Cancer Res; 1993 Mar; 53(5):1107-12. PubMed ID: 8439955 [TBL] [Abstract][Full Text] [Related]
16. Transduction of the IL-21 and IL-23 genes in human pancreatic carcinoma cells produces natural killer cell-dependent and -independent antitumor effects. Ugai S; Shimozato O; Yu L; Wang YQ; Kawamura K; Yamamoto H; Yamaguchi T; Saisho H; Sakiyama S; Tagawa M Cancer Gene Ther; 2003 Oct; 10(10):771-8. PubMed ID: 14502230 [TBL] [Abstract][Full Text] [Related]
17. Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-beta. Dong Z; Greene G; Pettaway C; Dinney CP; Eue I; Lu W; Bucana CD; Balbay MD; Bielenberg D; Fidler IJ Cancer Res; 1999 Feb; 59(4):872-9. PubMed ID: 10029078 [TBL] [Abstract][Full Text] [Related]
18. Production of interleukin 15 by human colon cancer cells is associated with induction of mucosal hyperplasia, angiogenesis, and metastasis. Kuniyasu H; Ohmori H; Sasaki T; Sasahira T; Yoshida K; Kitadai Y; Fidler IJ Clin Cancer Res; 2003 Oct; 9(13):4802-10. PubMed ID: 14581351 [TBL] [Abstract][Full Text] [Related]
19. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity. Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123 [TBL] [Abstract][Full Text] [Related]
20. Antileukemia activity of a natural killer cell line against human leukemias. Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]